MedTrace Logo

Establish the Referenc Range of Antiphospholipid Antibody in Healthy Preganany Women

NCT05883189 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-05-31

No results posted yet for this study

Summary

The study is aim to establish 95th and 99th percentile for healthy pregancy women for antiphospholipid antibodies(aPLs), such as aCL IgG/M/A, B2GP1 IgG/M/A, aPS/PT IgG/M. The outcome of the study is expected to aid Antiphospholipid syndrome patients diagnosis and managment. We also include some obstetirc Antiphospholipid syndrome(APS) patients to analysis the correlation between antiphospholipid antibodies and pregancy outcome, also want to know the prevalenc of aPLs, which can be guide for clinical application for APS diagnosis and treatment.

Conditions

  • Focus Health Pregancy Women

Interventions

DIAGNOSTIC_TEST

Draw blood

Draw blood from human body and make into serum to test

Sponsors & Collaborators

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-20
Primary Completion
2023-10-07
Completion
2024-02-28
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05883189 on ClinicalTrials.gov